Pharmaceutical Executive
January 06, 2010
Features
0
0
FDA Commissioner Margaret Hamburg has a history of health advocacy and a clear mandate to transform the agency. But can she succeed where others have failed?
December 01, 2009
0
0
China's explosive growth in R&D is putting the natiion on its way to becoming the world's second-largest market by 2020
December 01, 2009
Features
0
0
As the old orthodoxy shatters, pharma must stand firm or leave the field.
December 01, 2009
Columns
0
0
Marketers will need to address not only the benefits of the therapy but also the benefits of a diagnostic assay.
December 01, 2009
Washington Report
0
0
They already dominate the pharmaceutical market, and now generics are poised to move into biologics and complex dosage forms.
December 01, 2009
Columns
0
0
Process-driven managed-care rebating programs can drive profitability
December 01, 2009
Features
0
0
Our sixth annual pipeline report details 44 drugs that industry will be talking about in 2010.
December 01, 2009
From the Editor
0
0
The fight against cancer may be the litmus test for how regulation and private investment work together to address the disease burden.